VHIO spin-off Peptomyc receives approval to initiate its Phase Ib trial testing Omomyc in patients with metastatic pancreatic cancer

by VHIO

Peptomyc has received full study approval for its Phase Ib clinical trial evaluating the combination of its first-in-class MYC inhibitor Omomyc (OMO-103) with standard of care in metastatic pancreatic...

Read more

MYC inhibition in melanoma: preclinical promise and the unveiling of a pronostic gene signature

by VHIO

Results suggest that Omomyc MYC-targeted therapy could potentially open up a new treatment avenue for melanoma, and point to the future development of clinical trials to assess the efficacy of this mi...

Read more

Omomyc as the first MYC-targeted theraphy to succesfully complete a phase I clinical trial

by VHIO

Omomyc, a mini-therapeutic protein developed at the Vall d'Hebron Institute of Oncology (VHIO), has been shown in the preclinical phase in the laboratory to be able to enter cells and reach their nucl...

Read more

Omomyc, un fármaco desarrollado en Vall d’Hebron, llega al ensayo clínico

by Vall d’Hebron

​Después de demostrar su eficacia y buena tolerancia en modelos animales en el laboratorio, el tratamiento con Omomyc (OMO-103), un fármaco que inactiva a Myc, un gen clave para la proliferación ...

Read more

El inhibidor de Myc, Omomyc, entra en la recta final previa al ensayo clínico

by Vall d’Hebron

Peptomyc S.L., spin-off nacida del VHIO, ha producido Omomyc, la miniproteína inhibidora de Myc, y demostrado su actividad antitumoral tras administrarla por vía sanguínea por primera vez. El estud...

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Inbiomotion and SPA - Società Prodotti ...

by Inbiomotion

This pioneering test aids oncologists in predicting recurrence and sur...

Photos Stream